Abstract
The aim of this study was to evaluate cardiac performance, in particular diastolic function, in adult patients with adulthood onset GH deficiency. The study group was composed of 19 GH deficient adult hypopituitary patients with atleast 3 additional pituitary hormone deficits and 19 age, sex and BMI matched healthy controls. Mean duration of hypopituitarism was 108.6±77.0 months. None of the patients and controls presented with or had previous diagnosis of concomitant diseases that could affect cardiac function. All hormone deficiencies, except for GH, were appropriately replaced in the patients. Left ventricular function and geometry were evaluated by two-dimensional, M-mode and Doppler echocardiography. Body composition was evaluated by bioelectrical impedance analysis. Not significant differences were observed with respect to left heart dimensions and left ventricular systolic function between patients and controls. Nevertheless 2 of the left ventricular diastolic function parameters, deceleration time and isovolumetric relaxation time, were significantly prolonged in the patients compared with controls (247.88± 70.65 vs 143.26±31.70 milliseconds (ms) and 122.31±18.24 vs 89.47±12.12 ms respectively, p<0.001). Duration of hypopituitarism was significantly correlated with percent body fat mass (r=0.6119, p<0.01) and percent lean body mass (r=-0.5949, p<0.01). It is concluded that in adults affected by hypopituitarism, GH deficiency predominantly impairs diastolic function while systolic function at rest is spared. This observation might indicate a preclinical stage of a cardiomyopathy.
Similar content being viewed by others
References
Smallridge R.C., Rajfer S., Davia J., Schaaf M. Acromegaly and the heart:an echocardiographic study. Am. J. Med. 1979, 66: 22–27.
Özbey N., Öncül A., Buĝra Z., et al. Acromegalic cardiomyopathy: evaluation of the left ventricular diastolic function in the subclinical stage. J. Endocrinol. Invest. 1997, 20: 305–311.
Amato G., Carella C., Fazio S., et al. Body composition, bone metabolism and heart structure and function in growth hormone deficient adults before and after GH replacement therapy at low doses. J. Clin. Endocrinol. Metab. 1993, 77: 1671–1676.
Merola B., Cittadini A., Colao A., et al. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J. Clin. Endocrinol. Metab. 1993, 77: 1658–1661.
Frustaci A., Perrone G.A., Gentiloni N., Russo M.A. Reversible dilated cardiomyopathy due to growth hormone deficiency. Am. J. Clin. Pathol. 1992, 97: 503–511.
Fazio S., Biondi B., Sabatini D., et al. Long-term growth hormone deficiency as a cause of cardiomyopathy and its reversibility with specific replacement therapy. J. Clin. Endocrinol. Metab. 1996, 81: 887–890.
Johannsson G., Bengtsson B.A., Andersson B., Isgaard J., Caidahl K. Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients. Clin. Endocrinol. 1996, 45: 305–314.
Shahi M., Beshyah S.A., Hackett D., et al. Myocardial dysfunction in treated adult hypopituitarism; a possible explanation for increased cardiovascular mortality. Br. Heart. J. 1992, 67: 92–96.
Thuesen L., Jorgensen J.O., Muller J.R., et al. Short and long term cardiovascular effects of growth hormone therapy in growth hormone deficient adults. Clin. Endocrinol. 1994, 41: 615–620.
Dunne F.P., Elliot P., Gammage M.D., et al. Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism. Clin. Endocrinol. 1995, 43: 623–629.
Nass R., Huber R.M., Klauss V., et al. Effect of growth hormone replacement therapy on physical work capacity and cardiac and pulmonary function in patients with growth hormone deficiency acquired in adulthood. J. Clin. Endocrinol. Metab. 1995, 80: 552–557.
Valcavi R., Gaddi O., Zini M., et al. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. J. Clin. Endocrinol. Metab. 1995, 80: 659–666.
Longobardi S., Coucolo A., Merola B., et al. Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin. Endocrinol. 1998, 48: 137–143.
Nishimura R.A., Tajik A.J. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician’s Rosetta stone. J. Am. Coll. Cardiol. 1997, 30: 8–18.
Tresch D.D., McGough M.F. Heart failure with normal systolic function: a common disorder in older people. J. Am. Geriatr. Soc. 1985, 43: 1035–1042.
Beshyah A.S., Shahi M., Skinner E., et al. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults. Eur. J. Endocrinol. 1994, 130: 451–458.
Sassolas G., Chazot F.B., Bachelot P.J., et al. GH deficiency in adults: an epidemiological approach. Eur. J. Endocrinol. 1999, 141: 595–600.
Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412–419.
Sahn D.J., DeMaria A., Kissio J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58: 1072–1083.
Devereux R.B. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization and comparison with other methods. Hypertension 1987, 9: 19–26.
Rosen T., Bengtsson B.A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990, 336: 285–288.
Carroli P.V., Christ E.R. and the members of Growth Hormone Research Society Scientific Committee. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J. Clin. Endocrinol. Metab. 1998, 83: 382–395.
Sartorio A., Ferrero S., Conti A., et al. Adults with childhood- onset growth hormone deficiency: effects of growth hormone treatment on cardiac structure. J. Intern. Med. 1997, 241: 515–520.
ter Maaten J.C., de Boer H., Kamp O., Stuurman L., van der Veen E.A. Long-term effects of growth hormone replacement in men with childhood-onset growth hormone deficiency. J. Clin. Endocrinol. Metab. 1999, 84: 2373–2380.
Toogood A.A., Beardwell C.G., Shalet S.M. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin. Endocrinol. 1994, 41: 511–516.
Fazio S., Cittadini A., Sabatini D., et al. Growth hormone and heart performance. A novel mechanism of cardiac wall stress regulation in human. Eur. Heart J. 1997, 18: 340–347.
Labovitz A.J., Pearson A.C. Evaluation of left ventricular diastolic function: clinical relevance and recent Doppler echocardiographic insight. Am. Heart J. 1987, 114: 836–851.
Dougherty A.H., Naccarelli G.V., Gray E.L., Hicks C.H., Goldstein R.A. Congestive heart failure with normal systolic function. Am. J. Cardiol. 1984, 54: 778–782.
Lorell B.H., Grossman W. Cardiac hypertrophy: the consequences for diastole. J. Am. Coll. Cardiol. 1993, 22: 318–325.
Gandhi S.K., Powers J.C., Nomeir A.M., et al. The pathogenesis of acute pulmonary edema associated with hypertension. N. Engl. J. Med. 2001, 344: 17–22.
Ito H., Hiroe M., Hirata Y., et al. Insulinlike growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 1993, 87: 1715–1721.
Loh E., Swain J.L. Growth hormone for heart failure — cause for cautious optimism. N. Engl. J. Med. 1996, 334: 856–857.
Yang R., Bunting S., Gillet N., Clark R., Jin H. Growth hormone improves cardiac performance in experimental heart failure. Circulation 1995, 92: 262–267.
Roupas P., Chou S.Y., Towns R.J., Kostyo J.L. Growth hormone inhibits activation of phosphatidylinositol phospholipase C in adipose plasma membranes: evidence for a growth hormone-induced change in G protein function. Proc. Natl. Acad. Sci. USA 1991, 88: 1691–1695.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Özbey, N., Sezgil, A., Oflaz, H. et al. Left ventricular diastolic function abnormalities in hypopituitary patients with GH deficiency: Evidence for a subclinical cardiomyopathy. J Endocrinol Invest 25, 590–597 (2002). https://doi.org/10.1007/BF03345081
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345081